Latest stories on CRDF
Cardiff Oncology Names Alland Interim Chief Medical Officer as Sidhu Steps Down
MarketWatch48 · neutralgeneral
Cardiff Oncology names Leila Alland interim chief medical officer
The Fly52 · neutralgeneral
Cardiff Oncology, Inc. (CRDF) files 8-K
SEC 8-K50 · neutralgeneral
Cardiff Oncology Appoints Leila Alland, MD, as Interim Chief Medical Officer
StockTitan52 · neutralgeneral
Cardiff Oncology, Inc. (CRDF) files 8-K
SEC 8-K50 · neutralgeneral
Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia
GlobeNewswire64 · neutralproduct/pr
Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia
StockTitan64 · neutralproduct/pr
Cardiff Oncology treatment of chronic myelomonocytic leukemia gets orphan status
The Fly64 · neutralproduct/pr
Cardiff Oncology, Inc. (CRDF) files 8-K
SEC 8-K50 · neutralgeneral
Cardiff Oncology, Nerviano Medical Sciences reach settlement
The Fly55 · neutralgeneral
Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement
GlobeNewswire50 · neutralgeneral
Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement
Business Insider50 · neutralgeneral
Cardiff Oncology, Inc. (CRDF) Presents at 8th Annual RAS-Targeted Drug Development Summit - Slideshow
Seeking Alpha50 · neutralgeneral
Cardiff Oncology to Participate in September 2026 Conferences
Business Insider55 · neutralgeneral
Cardiff Oncology downgraded to Market Perform from Outperform at William Blair
The Fly42 · neutralanalyst
William Blair downgrades Cardiff Oncology stock rating on rights uncertainty
Investing.com Analyst Ratings34 · bearishanalyst
Cardiff Oncology, Inc. (CRDF) files 8-K
SEC 8-K50 · neutralgeneral
Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
Business Insider67 · bullishproduct/pr
Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
GlobeNewswire63 · neutralproduct/pr
Cardiff Oncology completes $10 million financing transaction
TipRanks24 · bearishgeneral
Cardiff Oncology, Inc. (CRDF) files 8-K
SEC 8-K50 · neutralgeneral
Cardiff Oncology Announces $10 Million Registered Direct Offering to Strengthen Working Capital
InvestorsHub28 · bearishgeneral
Is Cardiff Oncology, Inc. (CRDF) Stock Undervalued Amid Legal Uncertainty and Future Cancer Drug Potential?
Yahoo Top56 · neutralanalyst
Cardiff Oncology, Inc. (CRDF) files 8-K
SEC 8-K50 · neutralgeneral